Clinical trial

Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients

NCT05023746

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Genetron lung cancer panel Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-08-30

PhaseN/A

Conditions

Non-Small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Interventions

Genetron lung cancer panelDIAGNOSTIC_TEST

Sponsors & collaborators

Genetron Healthlead sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciencescollaborator

Second Affiliated Hospital, Zhejiang University, School of Medicinecollaborator

Henan Cancer Hospitalcollaborator

The First Hospital of Jilin Universitycollaborator

Genetron Health (Beijing) Co., Ltd.collaborator

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05023746 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.